Gaudium IVF and Women Health Limited (GAUDIUMIVF) — Offer Document | 13 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Monitoring Agency Report confirms IPO proceeds utilization for Gaudium IVF
🔄 What Changed
Rs. 25.34 crore utilized by June 30, 2026; Rs. 5.76 crore allocated to Lucknow Hospital; capital expenditure delayed to FY2026-27
🔮 What's Next
Utilization of unutilized proceeds within SEBI limits; no changes to object purposes; future deployment to follow approved schedule
💡 Investor Takeaway
Proceeds are being used as disclosed, with minor delays but no material deviations, maintaining investor confidence in capital allocation transparency.

The Monitoring Agency Report for the quarter ended June 30, 2026 confirms that Gaudium IVF and Women Health Limited has utilized Rs. 25.34 crore of the Rs. 90.00 crore IPO proceeds, with Rs. 5.76 crore allocated to a new Lucknow Women's Hospital under General Corporate Purpose, while capital expenditure for new IVF centres remains delayed to FY2026-27. The report verifies no deviations from offer document disclosures, with all statutory approvals obtained and proceeds deployed as per plan, including Rs. 56.11 crore in fixed deposits and loan repayments.

📄 View Original Announcement (PDF)

About Gaudium IVF and Women Health Limited (GAUDIUMIVF)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹861.07 Cr P/E: 31.9 ROE: 50.0% ROCE: 52.1%

View full GAUDIUMIVF stock details →

📡 Get AI alerts when GAUDIUMIVF files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GAUDIUMIVF — Free

📊 More GAUDIUMIVF filings

See all GAUDIUMIVF filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GAUDIUMIVF files new disclosures

Track GAUDIUMIVF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GAUDIUMIVF — Free

Free account · 2 AI queries/day